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Molecular methods that characterize the Neisseria gonorrhoeae porin protein Por are needed to study
gonococcal pathogenesis in the natural host and to classify strains from direct clinical samples used with
nucleic acid amplification-based tests. We have defined the capabilities of por variable region (VR) typing and
determined suitable conditions to apply the method to direct clinical specimens. Nested PCR from spiked urine
samples detected 1 to 10 copies of template DNA; freezing spiked whole urine greatly reduced the ability to
amplify porB. In a laboratory model of mixed gonococcal infections, the por type of one strain could be
determined in the presence of a 100-fold excess of another. por VR typing was used to examine clinical samples
from women enrolled in studies conducted in Baltimore, Md., and Madagascar. por type was determined from
100% of paired cervical swab and wick samples from 20 culture-positive women from Baltimore; results for
eight individuals (40%) suggested infection with more than one strain. In frozen urine samples from Mada-
gascar, porB was amplified and typed from 60 of 126 samples from ligase chain reaction (LCR)-positive women
and 3 samples from LCR-negative women. The por VR types of 13 samples (21%) suggested the presence of
more than one gonococcal strain. Five por types, identified in >45% of women with typed samples, were
common to both geographic areas. Molecular typing is an important adjunct to nucleic acid amplification-
based diagnostics. Methods that utilize direct clinical samples and can identify mixed infections may contrib-
ute significantly to studies of host immunity, gonococcal epidemiology, and pathogenesis.
Reproductive tract infections caused by Neisseria gonor-
rhoeae (gonococci) remain a significant public health issue
throughout the world. Not only do gonococci cause uncompli-
cated gonorrhea, but infection can also lead to disseminated
disease, pelvic inflammatory disease, or salpingitis leading to
infertility, ectopic pregnancy, and chronic pain. Surveillance by
the Centers for Disease Control and Prevention indicated that
361,705 cases of gonorrhea were reported in 2001 in the
United States (5), and the World Health Organization esti-
mated that there were 62.35 million cases worldwide in 1999
(34).
The development and increased use of nucleic acid amplifi-
cation tests (NAAT) have had broad implications for the di-
agnosis and characterization of gonococcal infections. NAAT
are more sensitive than culture (32) and are used to test non-
cultured samples such as urine, vaginal swabs, and tampons
(15, 23, 26). Therefore, NAAT can be used to easily screen
individuals, including those who are asymptomatic, without the
need for a physical exam.
Reliance on bacterial cultures for characterization of infect-
ing strains is less feasible with increased use of newer molec-
ular diagnostic methods. A parallel evolution in molecular
approaches is needed to characterize strains for epidemiologic,
public health, and research purposes such as identification of
high-frequency transmitters and linked infections and studies
of transmission and spread of resistance (4, 10). The use of
NAAT has already opened new avenues of investigation; it has
detected organisms from culture-negative sexually transmitted
infections and identified the presence of multiple strains (16,
18). As N. gonorrhoeae is an obligate human pathogen which is
highly diverse, with extensive molecular mechanisms for ge-
netic exchange and recombination (13), it is likely that genetic
exchanges take place when more than one strain infects an
individual host. However, multiple infecting strains have been
infrequently recovered from cultures, and thus, new molecular
methods are needed that can reliably identify and characterize
multiple individual strains in direct noncultured clinical sam-
ples.
The porin protein (Por), the major outer membrane protein
of N. gonorrhoeae, is essential for bacterial viability, with all
strains expressing one of two mutually exclusive alleles, PIA
and PIB. Por is not phase variable and has been shown to be an
important factor in the pathogenicity of the organism; it has
been implicated in invasion in vitro (7, 11), and invasive dis-
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ease is associated with strains expressing a PIA allele (25). Por
has also been shown to contribute to serum resistance by bind-
ing complement regulatory proteins (22). Por is encoded by a
single-copy gene, porB, and antigenic diversity within each
allele has been localized to the eight predicted surface-exposed
loops encoded by porB variable regions (VR) (30). We have
previously described a genetic method for characterization of
Por in gonococci. This method uses oligonucleotide probes
with DNA-DNA hybridization to identify sequences of the
VR, i.e., the sequences coding for the putative surface-exposed
loops. The method characterizes sequences coding loops 1, 2,
3, 6, and 7 of the PIA porin and loops 1, 3, 5, 6, and 7 of the
PIB porin based on determinations of the genetic regions that
exhibit the highest levels of diversity (19, 27). Characterization
of Por diversity remains an important factor in the evaluation
of Por as a vaccine candidate.
In this study, we have adapted por VR typing for use with
non-culture-based clinical samples. We report on the ability
and limitations of our method to characterize porB from cer-
vical swab, cervical wick, and urine samples. We also report on
the diversity of por types and evidence suggesting that there are
mixed gonococcal infections detected in archived samples from
women from two divergent populations.
(This work was presented in part at the 15th Biennial Con-
gress of the International Society for Sexually Transmitted
Diseases Research, Ottawa, Ontario, Canada, 27 to 30 July
2003, and at the 13th International Pathogenic Neisseria Con-
ference, Oslo, Norway, 1 to 6 September 2002.)
METHODS AND MATERIALS
DNA preparation. (i) Bacterial strains. Strains used as por VR typing controls
have been previously described (19). Strains MS11mkC, FA1090, FA19, and
PI83 were used in spiked urine and mixed-strain experimental samples. Genomic
DNA for por VR typing controls was isolated from cultures grown overnight on
standard gonococcal agar plates by using a Wizard Genomic DNA purification
kit (Promega, Madison, Wis.). Genomic DNA from the following Neisseria spe-
cies was kindly provided by P. Zhu (Center for Biologics Evaluation and Re-
search, Food and Drug Administration, Bethesda, Md.): N. meningitidis (strain
H335), N. polysaccharea, N. lactamica, N. subflava, N. canis, N. cinerea, N. caviae,
N. elongata, N. flavescens, N. mucosa, N. ovis, N. sicca, and N. weaveri (35).
(ii) Experimental samples. Control urine was obtained from healthy volun-
teers and spiked with various dilutions of bacterial suspensions. Bacteria were
prepared from strains grown as described above and harvested into Dulbecco’s
phosphate-buffered saline with magnesium, calcium, and 0.1% gelatin diluted to
an optical density at 600 nm of approximately 0.1. Bacterial suspensions (CFU
per milliliter) were determined by colony counts on standard gonococcal plates;
the number of copies of template DNA was calculated based on the assumption
that each CFU contained two bacteria and, thus, two copies of porin DNA.
One-milliliter aliquots of spiked urine were centrifuged in a standard tabletop
centrifuge (Eppendorf 5415C) at 14,000 rpm for 10 min, and DNA was isolated
by using a High Pure DNA template kit (Roche Diagnostics Corporation, Indi-
anapolis, Ind.) according to the manufacturer’s instructions.
For evaluation of the effect of a freeze-thaw cycle on the ability to amplify porB
from urine, bacterial suspensions were added to control urine, aliquoted, and
subjected to various storage conditions. One set of aliquots was frozen, thawed,
and centrifuged at the time of use (frozen urine); a second set was centrifuged,
the supernatant was removed, and the pellet was stored frozen (frozen pellet);
and a third set was centrifuged and processed immediately (fresh). DNA was
isolated by using a Roche High Pure DNA template kit as described above.
To examine the ability of por VR typing to identify a mixture of different
strains, suspensions of PIA and PIB control strains were prepared. CFU deter-
minations were performed to confirm equivalent CFU per milliliter for each
strain suspension (Fig. 1). PIA and PIB suspensions were then diluted 1:10 and
1:100, and these dilutions were combined with the undiluted suspensions to give
ratios of PIA to PIB (CFU:CFU) of approximately 100:100, 100:10, 100:1, 1:100,
and 10:100. One milliliter of each of the mixtures was centrifuged and processed
for DNA as described above for the urine samples.
(iii) Clinical samples. Samples from two studies were obtained to evaluate por
VR typing from clinical specimens. In one study, subjects were a systematic
sample of patients presenting to Baltimore sexually transmitted disease clinics
from 1995 to 1996 (the Mucosal Immunology Study). For women who consented,
cervical culture for gonococci was performed, and cervical swab, cervical wick
(Sno-strip; Chauvin Pharmaceuticals Ltd., Essex, England), urine, and serum
samples were collected. Swabs and wicks were stored in phosphate-buffered
saline at 70°C. For positive cultures, a sweep of all growth was harvested from
the primary plate and stored at 70°C in 20% glycerol–tryptic soy broth. We
evaluated matched swabs and wicks from 20 subjects who were positive for N.
gonorrhoeae by culture and did not participate in subsequent visits of the original
study. The corresponding primary cultures, available for 17 participants, were
also evaluated. DNA was purified from approximately half of the volume of
buffer used to store the wick or swab (150 and 500 l, respectively) or approx-
imately 200 to 250 l of frozen culture stock. Samples were centrifuged, the
FIG. 1. por VR typing of PCR-amplified DNA from mixtures of
two bacterial suspensions using checkerboard hybridization. Suspen-
sions of PIB and PIA strains were mixed at different ratios, centri-
fuged, and DNA purified, and porB was PCR amplified. PCR product
was applied to the nylon membrane in columns on the basis of total
amplicon concentration; approximate CFU-to-CFU ratios shown, 100,
10, and 1, are equal to approximately 104, 103, and 102 CFU added to
the PCR, respectively. Biotin-labeled probes were hybridized in rows,
and probes that determine VR type are indicated by arrows. Shown are
two images of the same blot initially probed with PIA probes and
stripped and subsequently rehybridized with PIB probes. Both PIA and
PIB strains could be detected by por VR typing in the presence of a
100-fold-higher concentration of another strain. Probe PIB VR1-3 is
known to cross-react with VR1-1 (2-bp difference) based on compar-
ison to control strains (data not shown), and its binding does not
indicate a mixed por type.
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pellets were treated at 56°C for 30 min, and DNA was purified as described above
for the urine samples.
The second set of samples was first-void urine specimens collected as part of
a study designed to develop sexually transmitted infection control strategies for
female sex workers (SWs) in Madagascar which was conducted between May
2000 and January 2001 (2). Women provided specimens upon initial enrollment
and received presumptive treatment for gonorrhea and Chlamydia infection (1 g
of azythromycin and 500 mg of ciprofloxacin). A second specimen was collected
approximately 2 months later. Specimens were aliquoted into two tubes on site,
frozen at 20°C, and shipped on dry ice to the University of North Carolina,
where one aliquot was tested by ligase chain reaction (LCR) (LCx probe system;
Abbott Laboratories, Abbott Park, Ill.) and the other 0.1- to 5.0-ml aliquot was
stored at 70°C. A total of 393 urine samples from 269 subjects were available.
Urine samples 2 ml from both visits were available for 127 SWs, and 144
samples from the first 72 of these were arbitrarily chosen for por VR typing
blinded to LCR results as a pilot study to examine the utility of our methods. An
additional 31 of 41 LCR-positive samples that were 4 ml or greater were also
tested. Samples were thawed and centrifuged, and the pellets were treated at
56°C for 30 min and then DNA purified by using a Roche High Pure DNA
template kit as described above.
All studies were approved or exempted by the appropriate institutional review
committees at Johns Hopkins University, the University of North Carolina, and
the Center for Biologics Evaluation and Research.
DNA amplification. PCR amplifications were performed as previously de-
scribed (19) in 50-l reactions, using 10 l of template DNA for experimental
and noncultured samples or 1 l of template DNA from gonococcal cultures,
with 1 mol of each primer, 300 mol of deoxynucleoside triphosphate, 5 l of
10 PCR buffer with MgCl2, and 3.3 U of DNA polymerase with proofreading
enzyme (Expand High Fidelity PCR system; Roche). PCR for all samples was
performed by using primers GCPorBFouter (5-TCGGCGGTAAATGCAAAG
C-3 ) and GCPorBRouter (5-TGCAGATTAGAATTTGTGGCG-3). Nested
PCR was performed for the sensitivity determinations, the nongonococcal Neis-
seria species, and non-culture-based clinical samples by using primers PIB.Fpr
(5-ATTGCCCTGACTTTGGCAGCCCTTCCT-3 ) and PIB.Rpr (5-TTGCA
ACCAGCCGGCAGAAACCAAGGC-3 ) (27) and 10 l of the outer reaction
as template. Both sets of primers amplify both PIA and PIB porB. Product
concentration and size were determined by using the Agilent (Rockville, Md.)
2100 Bioanalyzer according to manufacturer’s instructions. Reactions using dis-
tilled water instead of template DNA served as negative controls for each set of
PCRs.
por VR typing. The biotin-labeled oligonucleotide probes matching coding
regions for the variable regions of porB have been described previously (19, 27).
Probes for PIA VRs 1, 2, 3, 6, and 7 (three, four, three, four, and three probes
for each VR, respectively), and PIB VRs 1, 3, 5, 6, and 7 (three, two, nine, six,
and three probes for each VR, respectively) were included for all assays. The
hybridizations were performed as described previously (19). Briefly, 400 ng of
denatured PCR-amplified por DNA was applied to Zeta-Probe-GT nylon mem-
branes (Bio-Rad, Hercules, Calif.) by using a 30-slot vacuum apparatus (Immu-
netics, Cambridge, Mass.). Probes were hybridized by using a 45-channel vacuum
apparatus (Immunetics) at 59°C for 3 h, and binding was visualized by using an
avidin-peroxidase conjugate (Roche Molecular Biochemicals) and chemilumi-
nescent substrate (ECL; Amersham Pharmacia Biotech, Piscataway, N.J.) fol-
lowed by exposure to photographic film. Hybridization signals were assessed
visually and compared to those of control strains.
Hybridization results for a single VR are referred to as “VR type,” and in
instances where more than one probe is hybridized for a single VR, each probe
is listed separated by a comma. The por VR type includes results for all VRs
tested, listed sequentially separated by a semicolon, e.g., PIA 1;2;1;1;1 denotes a
strain hybridizing PIA VR1-1, VR2-2, VR3-1, VR6-1, and VR7-1 probes. Nt
indicates an individual VR that failed to hybridize with the current panel of
probes. A mixed por type was defined as hybridization of dissimilar probes
(differing by 4 bp) at each of two or more individual VRs.
RESULTS
The goal of this study was to demonstrate the ability of our
methods to amplify and characterize porB from a variety of
experimental samples under different storage conditions and in
the presence of more than one strain. We then used these
methods to characterize gonococcal por VR types in available
archived samples from two clinical studies.
Sensitivity of nested porB PCR and effects of sample han-
dling. The sensitivity of the nested PCR was determined for
two PIB strains, MS11mkCe and FA1090, diluted into two
different urine samples, one of which was shown to inhibit
PCR. Sufficient product for subsequent por typing was gener-
ated in the nested PCR when 1 to 10 copies of template DNA
were added to the PCR.
To determine the effect of a freeze-thaw cycle on the ability
to amplify porB DNA from urine, we quantified the amplicon
from PCR performed on DNA purified from urine spiked with
serial dilutions of bacterial suspensions and stored under var-
ious conditions. Only the outer PCR was performed; bacterial
suspensions ranged from approximately 106 to 102 CFU/ml.
After a single freeze-thaw cycle, a 10-fold-higher concentration
of bacteria was required to generate a detectable PCR product,
and a 100-fold-higher concentration was necessary to yield a
quantifiable amount of PCR product compared to a sample
that had not been frozen. However, freezing the pellet alone
after removing the supernatant did not result in a substantial
loss of amplifiable DNA (Table 1).
por VR typing of mixed strains. To examine the ability of por
VR typing to identify more than one gonococcal isolate in a
single sample, suspensions of a PIB isolate and a PIA isolate
were mixed at various concentrations, DNA was purified and
amplified, and por VR typing was performed. Purification,
amplification, and por VR typing were achieved with as little as
10 to 102 copies of template DNA from either strain, even in
the presence of a 100-fold excess of the other strain (Fig. 1).
Commensal Neisseria species. Genomic DNA from each of
13 Neisseria species was used as a template for porB amplifi-
cation and VR probe hybridization. No PCR product was ob-
served from either the outer or the nested reactions for N.
canis, N. cinerea, N. caviae, N. flavescens, N. mucosa, N. ovis, N.
sicca, and N. weaveri. The outer and/or nested PCR amplified
a DNA fragment in the range of 871 to 1,192 bases (similar to
the size of the expected product generated by amplification of
gonococci) for N. meningitidis, N. polysaccharea, N. lactamica,
N. subflava, and N. elongata. None of the PCR products ob-
tained from nongonoccocal Neisseria species hybridized any of
the gonococcal por VR probes.
por VR typing from matched cervical wick, swab, and culture
samples. Paired cervical swabs and cervical wicks from 20
women were examined, along with corresponding stored cul-
ture samples for 17 of these women. PCR product and typing
results were obtained for all samples. Eight of 20 women had
evidence of more than one por type. Multiple por types were




PCR product concn (ng/l)a
Fresh Frozen pellet Frozen urine
101 37 26 22
102 10  4
103 10 8 
104 4 1.5 
105   
a A  indicates samples that generated a visible band below the limit of
quantitation (1 ng/l). A  indicates a sample that generated no visible band.
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detected from the wicks from four women, multiple por types
were detected from the swabs from two women, and results
from wicks and swabs from two women were discordant (Fig.
2A and B). In half (four of eight) of the samples, both a PIA
and a PIB type were detected, and the remaining four samples
had evidence of more than one PIB strain. No mixed por types
were found in DNA purified from the stored culture samples;
however, the por type identified in the DNA from each culture
sample matched one of the por types identified in the corre-
sponding cervical samples (Fig. 2B). The por type in the DNA
from the culture sample matched the por type in the DNA
from the swab in one of two discordant samples and matched
the PIA strain in all three PIA/PIB mixed infections where a
culture sample was available.
Overall, 18 por types were identified: 15 PIB types among 17
women and 3 PIA types among 6 women (4 who also had a PIB
strain identified). One woman was infected with a PIA/PIB
hybrid strain in which VR1 was typed as PIB and VRs 3, 6, and
7 were typed with PIA probes, suggesting a point of recombi-
nation between the regions encoding loops 2 and 3. Figure 3A
shows the percentage of women with PIA, PIB, or mixed por
types, and Fig. 4 shows the overall distribution of por types in
the samples tested. To assess the reproducibility of our
method, results for eight samples, including some mixed por
VR types and the hybrid type, were confirmed by reamplifica-
tion of the purified DNA and retyping.
por VR typing from urine samples obtained from female sex
workers. To explore the utility of por VR typing for clinical
studies in which urine is often collected for sexually transmit-
ted disease testing, we attempted to type gonococci from
stored frozen urine collected from female SWs in Madagascar
(2). Samples obtained at two visits approximately 2 months
apart had been stored frozen for 2 to 2[1/2] years. The first 144
samples were subjected to an analysis blinded with respect to
FIG. 2. Detection of multiple por VR types in clinical samples using checkerboard hybridization blots. PCR amplicons were applied to nylon
membranes in columns, and probes were hybridized in rows. Arrows show hybridized probes that determine VR type. Where two sets of probes
are indicated (panels A and C), the images are of the same blot, stripped and rehybridized. Shown are hybridization profiles of amplicons from
samples from three women that demonstrate the presence of multiple por VR types. (A) Discordant cervical wick and cervical swab samples from
a woman enrolled in Baltimore. The por VR type was PIB in the wick and was PIA in the swab. (B) Matched cervical wick, swab, and culture
samples from a second woman enrolled in Baltimore. The culture, wick, and swab all contained one similar por VR profile; however, the swab
sample bound additional probes (VR5-8 and VR6-1), suggesting the presence of a second strain with a different por type. Probes PIB VR5-3 and
VR5-8 differ from each other by 11 bp, and PIB VR6-1 and VR6-5 differ by 10 bp; hybridization of these probes indicates the presence of two
different PIB porB genes. (C) Hybridization pattern of porB PCR products from a single urine sample from a female SW enrolled in Madagascar.
Hybridization of PIA probes, two PIB VR3 probes (right), two PIB VR1 probes, two PIB VR5 probes, and two PIB VR6 probes (left) suggests
the presence of at least three por types. The PIB probes hybridized for VRs 1, 3, 5, and 6 differ by 10, 6, 3, and 6 bp, respectively. The hybridized
PIA probes differed from PIB probes that bound to corresponding VRs by 6 to 12 bp.
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LCR results, and amplification products were obtained from
48 of these 144 samples. por type was determined for 44 sam-
ples from 36 SWs: 25 of 53 LCR-positive (47%) and 1 of 19
LCR-negative (5%) samples from visit 1, and 16 of 42 LCR-
positive (38%) and 2 of 30 LCR-negative (7%) samples from
visit 2. The remaining four PCR-amplified samples did not
hybridize any of the VR probes, consistent with the results
from commensal Neisseria species. An additional 31 LCR-
positive samples with larger available urine volumes (4 ml)
were processed, and por type was determined for 8 of 15
samples from visit 1 (53%) and 11 of 16 samples from visit 2
(68%). In total, we amplified and typed porB in 63 samples
from 53 SWs.
Thirteen of the 63 por VR-typed samples had results con-
sistent with multiple por types (21%). Four samples indicated
two PIA types, and two samples were from the two visits of a
single SW. Coinfection with a PIA and a PIB strain was iden-
tified in nine samples, and two of these samples were from one
woman. One of the PIA/PIB mixed samples had evidence of
two different PIB por types, indicating the presence of DNA
from at least three strains (Fig. 2C). In the remaining typed
samples, 23 (37%) had a single PIB por type and 27 (43%) had
a single PIA por type (Fig. 3B and 4).
Overall, 10 PIB por types were identified among 32 samples
from 28 SWs, and three types accounted for 23 (72%) of the
samples. Ten PIA por types were identified among 40 samples
from 35 SWs, and three types accounted for 26 (65%) of the
samples. PCR-positive and typeable results were obtained
from urine at both the first and second visits for 10 subjects. Of
these samples, four had the same por type or types at both
visits, three had completely different por types at each visit, and
three had the same por type at both visits but also had a second
por type at one of the two visits. To assess the reproducibility
of our typing method, results for 12 samples, including the
sample with evidence of three different por VR types, were
confirmed by reamplification of the purified DNA and retyp-
ing.
Comparison of por VR typing in Baltimore and Madagascar
samples. Calculation of the frequency of individual por types
was complicated by the presence of mixed por types. Mixed
PIA and PIB types were treated as individual PIA and PIB por
types, and three of four individuals from Baltimore with more
than one PIB type could be resolved into separate types by
comparisons among cervical and culture samples. Five sus-
pected coinfections with more than one PIA strain identified in
urine samples were each treated as unique combined por types.
This approach may have underestimated the frequency of the
composite types and overestimated the diversity of PIA por
types, but an overall picture of porB diversity within and among
the sample sets was still possible (Fig. 4). Several por types
were identified in both sets of samples described here (Table
2).
Analysis of individual VRs indicated that the panel of VR
probes used in this study was highly relevant to both sets of
samples. Among 63 Madagascar samples, one common PIB
strain was nontypeable in VR5, one PIA sample was nontype-
able in VR1, and another PIA sample was not typed in VR1
and VR2. In the Baltimore samples, one PIB strain was non-
typeable in VR5 and VR7.
DISCUSSION
This study expands our earlier work with por VR typing of
culture samples by applying this method to noncultured clinical
samples. Adapting the method for use with direct clinical sam-
ples allowed us to investigate the possible occurrence of coin-
fection with multiple gonococcal strains in more detail than
previously reported as well as to examine the range of por types
identified in two very divergent populations.
The use of NAAT in conjunction with the ability to charac-
terize strains from direct clinical samples may have an impor-
tant impact on the study of N. gonorrhoeae. Turner et al. (28)
estimated that the prevalence of undiagnosed gonococcal in-
fections in a young adult population in Baltimore was 5.3% by
FIG. 3. Distribution of PIA, PIB, hybrid, and mixed por types. Percentages of women with PIA, PIB, hybrid, or mixed por types for each study
are shown. (A) Women enrolled in the study in Baltimore for whom por type was determined; (B) women enrolled in the study in Madagascar
for whom por type was determined.
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using NAAT, much higher than the 2.6% prevalence estimate
based on diagnosed and reported infections in the same pop-
ulation. In Australia, a study using NAAT found that the
estimated number of women infected was over four times the
number of officially reported cases (3). The characteristics of
isolates causing infections identified by NAAT have not been
routinely examined, and epidemiologic studies utilizing NAAT
will be enhanced by the use of methods that provide molecular
characterization of strains.
In addition to potential application with current NAAT, por
VR typing is based on characterization of a single-copy gene
and is therefore able to distinguish single, multiple, or hybrid
por types present in a single sample. Our previous data dem-
onstrated that the oligonucleotide probes do not cross-react
with sequences that differ by more than 2 bp and are highly
specific for the sequences found in the variable regions of porB
(19, 27). Sequence analysis of neisserial porB genes has shown
that while genetic exchange occurs between genes, exchange
does not occur between VRs within a single porB gene (1, 9, 12,
24, 27, 29, 33). For example, sequences found in VR1 are
unique to that VR and are not found in any other VR in the
gene. Given the specificity of the oligonucleotide probes, hy-
bridization of distinctly different probes for the same VR re-
gion strongly suggests that DNA from more than one strain
was present in the sample. Mixed gonococcal infections may be
significant in many aspects of gonococcal research, including
studies of natural immunity, transmission, spread of antimicro-
bial resistance, and genetic diversification. The extensive
mechanisms present in N. gonorrhoeae for genetic exchange
and recombination have been recently reviewed (13). Since the
only ecologic niche occupied by gonococci is the human host,
mixed infections are central to the evolution of this pathogen.
Typing directly from clinical specimens identified multiple
por types from a remarkable 40% of the women in the Balti-
more study and from 22% of specimens from SWs from Mada-
gascar. While the specimens that were used for this exploratory
study do not allow estimates of the prevalence of mixed infec-
tions in any population, the data suggest that mixed infections
are far more common than previously appreciated. Knapp et
al. had previously reported a rate of approximately 21% when
isolating N. gonorrhoeae from multiple sites in men and women
and identifying different auxotype/serovar classes from each
site (14). However, the identification of multiple auxotype/
serovar types in a single mixed isolate would be difficult, as the
serovar system uses a panel of monoclonal antibodies and
unusual binding patterns may be due to either usual serovars
FIG. 4. Distribution of por types from study samples for which
typing data were obtained. The inner circle shows por types identified
from Baltimore, and the outer circle shows those identified from
Madagascar. Women with mixed PIA/PIB por types contribute to the
totals for each por type. Mixed PIA/PIA por types were treated as a
unique PIA type, and mixed PIB/PIB types that could not be separately
identified were counted as a unique PIB type. A total of 6 women had
1 of 3 PIA por types and 17 women had 1 of 15 PIB types in Baltimore;
a total of 35 women had 1 of 10 PIA types and 28 women had 1 of 10
PIB types in Madagascar. The most commonly identified por types are
listed by lowercase letters corresponding to the labeled graphic. The
por types that were observed in both geographic locations are in white.
The por types unique to each group are shaded. por types occurring
only once are indicated by an asterisk.
TABLE 2. por types common to women in Baltimore
and Madagascar
Allele por typea
% of women with
por typeb
Baltimore Madagascar
PIA A:1;2;1;1;1 (b) 10 17
A:1;3;1;1,4;1 (e) 15 4




PIB B:3;2;8;1;3 (c) 10 13
B:1;1;2;2;1,3 (g) 10 2
B:2;1;5,6;5;3 (d) 10 8




Total % of women with
por types observed in
both locations
55 44
a The por VR type includes results for all VRs tested listed sequentially
separated by a semicolon; where more than one probe is hybridized for a single
VR, each probe listed is separated by a comma. Letters in parentheses designate
legend for that strain in Fig. 4.
b The percentages are based on the total number of women for whom typing
data were obtained.
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(such as those seen in hybrid or rare porin types) or mixed
infections. Martin and Ison (18) recently raised this issue by
comparing the opa type of direct urethral specimens with the
opa type of the primary culture. In that study, 19 samples (14
from men and 5 from women) were examined, and four men
(21%) had evidence of a mixed gonococcal infection. Those
authors did not detect multiple strains in cultures, even by
typing multiple individual colonies of the primary isolation
plate. In our study, DNA purified from stored culture samples
also did not contain evidence of multiple strain types. We did
not attempt to identify por types of single colonies grown from
the culture samples, as we avoided possible secondary selection
by purifying DNA directly from an aliquot of the stock pre-
pared from the primary culture plate. Since amplification and
identification of one porB in the presence of a 100-fold excess
of another porB was possible, this approach should be more
sensitive than screening several hundred colonies.
The discrepancy between the ability to detect mixed infec-
tions in stored cultures and the ability to detect mixed infec-
tions in stored clinical specimens could have several plausible
explanations. Nonviable and live gonococci would be detected
by DNA amplification from clinical samples, whereas only vi-
able gonococci would be recovered by culture. Differences in in
vitro growth kinetics might bias detection towards more robust
strains that grow well on standard culture media. Even if two
strains were present on a culture plate, they would not neces-
sarily be distinguishable by colony morphology, and multiple
single-colony analyses would be necessary to identify and char-
acterize both strains. So although not a factor in this study,
isolation of a single colony to characterize an infecting strain
may have underestimated mixed infections in previous studies.
The use of NAAT diagnostics combined with molecular meth-
ods of strain characterization may greatly improve our under-
standing of the frequency and consequences of mixed gono-
coccal infections.
Although comparisons of the diversity of por types between
Baltimore and Madagascar are limited by the differences in
study design, some general observations can be made. A high
proportion of individuals for whom typing data were obtained
had a por type common to both geographic areas. Our earlier
study of Baltimore isolates collected over 10 years (19) sug-
gested that approximately 10 to 33% of cultures were PIA,
which is consistent with the findings of the present study as well
as those of others (14). The unusually high number of PIA
strains in the Madagascar SWs, in which 66% of women had at
least one PIA strain, may be a consequence of factors including
the number of exposures, general physical condition, and im-
mune status. The differential ability of PIA compared to PIB
strains to be isolated outside the genital tract, survive in the
harsh environment of urine, and remain intact during storage
and handling may affect the detection of different por types.
Additionally, we were not able to amplify and type all of the
samples that were LCR positive, and we cannot exclude the
possibility of sample bias affecting the relative prevalence of
PIA- compared to PIB-expressing strains observed in this
study. However, given that more serious, invasive, and dissem-
inated disease has been associated with strains expressing PIA,
the predominance of PIA in this population deserves further
investigation.
The PCR primers used in this study were specifically de-
signed to amplify both PIA and PIB alleles of porB. Due to the
conserved nature of the of neisserial porins, the primers also
amplified DNA from some commensal Neisseria species. Other
NAAT systems also detect nongonococcal genes (8, 20, 21, 31).
Our data suggest, however, that gonococcal porB probes do not
hybridize to porin DNA amplified from commensal Neisseria,
allowing accurate characterization of the gonococcal porin
even in the presence of commensal Neisseria.
We were unable to amplify porB from many of the LCR-
positive urine samples. Experimentally, we demonstrated the
loss of an order of magnitude in sensitivity associated with a
single, brief freeze-thaw cycle of whole urine, and additional
losses may be associated with extended storage time. The Ab-
bott GC LCR targeted the multicopy gene opa rather than the
single-copy gene porB targeted by por VR typing. LCR may be
more sensitive than PCR; no PCR-based NAAT is widely
available for the detection of gonococci in urine from women.
por VR typing is not designed to be a diagnostic test per se but
rather a method that can be used in conjunction with NAAT to
characterize strains in individuals who have been identified as
having gonococcal infections. Several studies have shown that
endocervical and vaginal samples are more sensitive than urine
for detecting gonococci in women (6, 15, 17, 23, 26), and the
use of self-collected vaginal swabs might be a viable alternative
(17, 26). In studies where urine samples are collected, centri-
fuging the samples and storing the pellets alone may improve
subsequent genotypic analyses.
In these studies, we demonstrated the utility of molecular
characterization of the gonococcal outer membrane Por pro-
tein from non-culture-based clinical samples. We have also
shown that evidence of infections with multiple strains can be
easily identified in direct clinical specimens. Additionally, our
data support our earlier findings that some por types and some
VR types are common among geographically diverse popula-
tions. The combination of a molecular typing method with
NAAT will enhance our understanding of the molecular epi-
demiology of N. gonorrhoeae. Our understanding of the signif-
icance of gonococcal por type and mixed infections in studies of
protective immunity, strain transmission, reinfection, and an-
timicrobial resistance will be substantially enhanced by using
direct clinical specimens and methods that provide specific and
accurate information about porB.
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